Mouse only (beta-thalassemic and wild-type C57BL/6 transplant models; immunodeficient mice for human cells)
“The following toxicology studies were conducted to evaluate the safety of human HSCs or mBMCs transduced with BB305 LVV following administration in mice.”
✓ VerifiedFDA pharmacology/toxicology review, p. 16Source ↗
Why that species
Beta-thalassemic (Hbbth1/th1) mouse disease model allowed pharmacology and toxicity assessment of transduced syngeneic marrow
“To evaluate the pharmacologic and toxicologic effects of mBMCs transduced with BB305 LVV or mBMCs transduced with HPV569 LVV following IV administration in β-thalassemic mice.”
✓ VerifiedFDA pharmacology/toxicology review, p. 17Source ↗
Surrogate molecule
Yes: murine bone marrow cells transduced with clinical BB305 vector (homologous cell product); human CD34+ in immunodeficient mice
“Test Articles • mBMCs transduced with BB305 LVV (Lot No. • mBMCs transduced with HPV569 LVV (Lot No. Control Article mBMCs; mock-transduced”
✓ VerifiedFDA pharmacology/toxicology review, p. 17Source ↗